 | • レポートコード：MRC2302C078 • 出版社/出版日：360iResearch / 2023年2月3日 • レポート形態：英語、PDF、225ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に298.4億ドルであった世界の病理解剖市場規模が、2022年に320.1億ドルに達し、2027年には年平均成長率7.45%で459.4億ドルまで成長すると予測しています。当調査レポートでは、病理解剖の世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、サービス別（細胞病理検査サービス、病理組織検査サービス）、製品別（消耗品、機器）、用途別（疾患診断、医学研究）、エンドユーザー別（臨床検査室、病院検査室）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、Agilent Technologies, Inc、Amos Scientific Pty Ltd、Becton, Dickinson and Company、Bio SB、BioGenex Laboratories、Cardinal Health, Inc.、Diapath S.p.A.、Enzo Biochem, Inc.、F. Hoffmann-La Roche Ltd.、Histo-Line Laboratories、Hologic, Inc.、Jinhua Yidi Medical Appliance Co. Ltd、Merck KGaA、Milestone Medical Technologies Inなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の病理解剖市場規模：サービス別 - 細胞病理検査サービスの市場規模 - 病理組織検査サービスの市場規模 ・世界の病理解剖市場規模：製品別 - 消耗品の市場規模 - 機器の市場規模 ・世界の病理解剖市場規模：用途別 - 疾患診断における市場規模 - 医学研究における市場規模 ・世界の病理解剖市場規模：エンドユーザー別 - 臨床検査室における市場規模 - 病院検査室における市場規模 ・世界の病理解剖市場規模：地域別 - 南北アメリカの病理解剖市場規模 アメリカの病理解剖市場規模 カナダの病理解剖市場規模 ブラジルの病理解剖市場規模 … - アジア太平洋の病理解剖市場規模 日本の病理解剖市場規模 中国の病理解剖市場規模 インドの病理解剖市場規模 韓国の病理解剖市場規模 台湾の病理解剖市場規模 … - ヨーロッパ/中東/アフリカの病理解剖市場規模 イギリスの病理解剖市場規模 ドイツの病理解剖市場規模 フランスの病理解剖市場規模 ロシアの病理解剖市場規模 … - その他地域の病理解剖市場規模 ・競争状況 ・企業情報 |
The Global Anatomic Pathology Market size was estimated at USD 29.84 billion in 2021 and expected to reach USD 32.01 billion in 2022, and is projected to grow at a CAGR 7.45% to reach USD 45.94 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Anatomic Pathology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Services, the market was studied across Cytopathology and Histopathology.
Based on Prōduct, the market was studied across Consūmables and Instrūments. The Consūmables is further studied across Antibodies, Kits & Reagents, and Probes. The Instrūments is further studied across Cell Processors, Coverslippers, Embedding Systems, Microtomes, Slide Staining Systems, and Tissue Processing Systems.
Based on Applīcatiōn, the market was studied across Disease Diagnostics and Medical Research.
Based on End User, the market was studied across Clinical Laboratories and Hospital Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Anatomic Pathology market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anatomic Pathology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anatomic Pathology Market, including Agilent Technologies, Inc, Amos Scientific Pty Ltd, Becton, Dickinson and Company, Bio SB, BioGenex Laboratories, Cardinal Health, Inc., Diapath S.p.A., Enzo Biochem, Inc., F. Hoffmann-La Roche Ltd., Histo-Line Laboratories, Hologic, Inc., Jinhua Yidi Medical Appliance Co. Ltd, Merck KGaA, Milestone Medical Technologies In, NeoGenomics Laboratories, Inc., PHC Holdings Corporation, Quest Diagnostics Incorporated, RareCyte, Inc., Sakura Finetek USA, Inc., Thermo Fisher Scientific, Inc., and VolitionRx Limited.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Anatomic Pathology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anatomic Pathology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anatomic Pathology Market?
4. What is the competitive strategic window for opportunities in the Global Anatomic Pathology Market?
5. What are the technology trends and regulatory frameworks in the Global Anatomic Pathology Market?
6. What is the market share of the leading vendors in the Global Anatomic Pathology Market?
7. What modes and strategic moves are considered suitable for entering the Global Anatomic Pathology Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising reliance on biomarkers-based pathology tests and procedures
5.1.1.2. Increasing prevalence of cancer and other chronic diseases
5.1.1.3. Availability of reimbursement policies
5.1.1.4. Growing use of advanced pathology equipment such as gross imaging, staining systems, and digital microscopes
5.1.2. Restraints
5.1.2.1. Increased operational overheads with every subspecialty operating
5.1.3. Opportunities
5.1.3.1. Efforts towards advanced and upgraded pathology equipment
5.1.3.2. Strategic partnership and agreement among companies for the introduction of an effective portfolio
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Cumulative Impact of COVID-19
6. Anatomic Pathology Market, by Services
6.1. Introduction
6.2. Cytopathology
6.3. Histopathology
7. Anatomic Pathology Market, by Prōduct
7.1. Introduction
7.2. Consūmables
7.3.1. Antibodies
7.3.2. Kits & Reagents
7.3.3. Probes
7.3. Instrūments
7.4.1. Cell Processors
7.4.2. Coverslippers
7.4.3. Embedding Systems
7.4.4. Microtomes
7.4.5. Slide Staining Systems
7.4.6. Tissue Processing Systems
8. Anatomic Pathology Market, by Applīcatiōn
8.1. Introduction
8.2. Disease Diagnostics
8.3. Medical Research
9. Anatomic Pathology Market, by End User
9.1. Introduction
9.2. Clinical Laboratories
9.3. Hospital Laboratories
10. Americas Anatomic Pathology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Anatomic Pathology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Anatomic Pathology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Amos Scientific Pty Ltd
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Becton, Dickinson and Company
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bio SB
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BioGenex Laboratories
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Cardinal Health, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Diapath S.p.A.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Enzo Biochem, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. F. Hoffmann-La Roche Ltd.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Histo-Line Laboratories
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Hologic, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Jinhua Yidi Medical Appliance Co. Ltd
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Merck KGaA
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Milestone Medical Technologies In
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. NeoGenomics Laboratories, Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. PHC Holdings Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Quest Diagnostics Incorporated
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. RareCyte, Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Sakura Finetek USA, Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Thermo Fisher Scientific, Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. VolitionRx Limited
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing